A survey of patient preferences for a placebo orodispersible tablet

Figures & data

Table 1 Demographic characteristics, ITT analysis set (n = 150)

	n (%)
Age (years)
18–30	16 (10.7%)
31–45	48 (32.2%)
45–60	62 (41.6%)
60–80	23 (15.4%)
Missing	1
Gender
Male	51 (34.0%)
Female	99 (66.0%)
Race
Caucasian	148 (99.3%)
Other	1 (0.7%)
Missing	1

Note: Percentages are expressed as percentage of patients with data.

Table 2 Hospital anxiety and depression (HADS) scale scores, ITT analysis set (n = 150)

Parameter
Anxiety: total HADS-A score
Median	13
Range	3–21
Q1, Q3	10, 15
Category, n (%)
Abnormal	105 (70%)
Borderline normal	33 (22%)
Normal	12 (8%)
Depression: total HADS-D score
Median	11
Range	1–14
Q1, Q3	8, 14
Category, n (%)
Abnormal	77 (51.3%)
Borderline normal	44 (29.3%)
Normal	29 (19.3%)

Notes: Categories of anxiety and depression levels were defined based on HADS scale scores in which 0–7 = normal, 8–10 = borderline abnormal, and 11–21 = abnormal.

Abbreviations: HADS-A, hospital anxiety and depression scale (anxiety); HADS-D, hospital anxiety and depression scale (depression); ITT, intention to treat.